6p6c
From Proteopedia
(Difference between revisions)
												
			
			| m  (Protected "6p6c" [edit=sysop:move=sysop]) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==CS-Rosetta Model of PEA-15 Death Effector Domain in the Complex with ERK2== | |
| + | <StructureSection load='6p6c' size='340' side='right'caption='[[6p6c]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[6p6c]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6P6C OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6P6C FirstGlance]. <br> | ||
| + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6p6c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6p6c OCA], [http://pdbe.org/6p6c PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6p6c RCSB], [http://www.ebi.ac.uk/pdbsum/6p6c PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6p6c ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/PEA15_HUMAN PEA15_HUMAN]] Blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. Inhibits RPS6KA3 activities by retaining it in the cytoplasm (By similarity). Inhibits both TNFRSF6- and TNFRSF1A-mediated CASP8 activity and apoptosis. Regulates glucose transport by controlling both the content of SLC2A1 glucose transporters on the plasma membrane and the insulin-dependent trafficking of SLC2A4 from the cell interior to the surface.<ref>PMID:9670003</ref> <ref>PMID:10442631</ref>   | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Phosphoprotein enriched in astrocytes, 15 kDa (PEA-15) exerts its regulatory roles on several critical cellular pathways through protein-protein interactions depending on its phosphorylation states. It can either inhibit the extracellular signal-regulated kinase (ERK) activities when it is dephosphorylated or block the assembly of death-inducing signaling complex (DISC) and the subsequent activation of apoptotic initiator, caspase-8, when it is phosphorylated. Due to the important roles of PEA-15 in regulating these pathways that lead to opposite cellular outcomes (cell proliferation vs. cell death), we proposed a phosphostasis (phosphorylation homeostasis) model, in which the phosphorylation states of the protein are vigorously controlled and regulated to maintain a delicate balance. The phosphostasis gives rise to the protective cellular functions of PEA-15 to preserve optimum cellular conditions. In this article, using advanced multidimensional nuclear magnetic resonance (NMR) techniques combined with a novel chemical shift (CS)-Rosetta algorithm for de novo protein structural determination, we report a novel conformation of PEA-15 death-effector domain (DED) upon interacting with ERK2. This new conformation is modulated by the irregularly structured C-terminal tail when it first recognizes and binds to ERK2 at the d-peptide recruitment site (DRS) in an allosteric manner, and is facilitated by the rearrangement of the surface electrostatic and hydrogen-bonding interactions on the DED. In this ERK2-bound conformation, three of the six helices (alpha2, alpha3, and alpha4) comprising the DED reorient substantially in comparison to the free-form structure, exposing key residues on the other three helices that directly interact with ERK2 at the DEF-docking site (docking site for ERK, FxF) and the activation loop. Additionally, we provide evidence that the phosphorylation of the C-terminal tail leads to a distinct conformation of DED, allowing efficient interactions with Fas-associated death domain (FADD) protein at the DISC. Our results substantiate the allosteric regulatory roles of the C-terminal tail in modulating DED conformation and facilitating protein-protein interactions of PEA-15. | ||
| - | + | PEA-15 C-Terminal Tail Allosterically Modulates Death-Effector Domain Conformation and Facilitates Protein-Protein Interactions.,Crespo-Flores SL, Cabezas A, Hassan S, Wei Y Int J Mol Sci. 2019 Jul 7;20(13). pii: ijms20133335. doi: 10.3390/ijms20133335. PMID:31284641<ref>PMID:31284641</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | <div class="pdbe-citations 6p6c" style="background-color:#fffaf0;"></div> | |
| - | [[Category:  | + | == References == | 
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| [[Category: Cabezas, A]] | [[Category: Cabezas, A]] | ||
| + | [[Category: Flores, S Crespo]] | ||
| + | [[Category: Hassan, S]] | ||
| [[Category: Wei, Y]] | [[Category: Wei, Y]] | ||
| + | [[Category: Apoptosis]] | ||
| + | [[Category: Map kinase]] | ||
| + | [[Category: Protein-protein interaction]] | ||
Revision as of 06:25, 24 July 2019
CS-Rosetta Model of PEA-15 Death Effector Domain in the Complex with ERK2
| 
 | |||||||||||
